Background: Chemotactic cytokines, referred to as chemokines, play an important role in leukocyte trafficking. The circulating levels of chemokines have been shown to increase in inflammatory processes including obesity-related pathologies (e.g. atherosclerosis and diabetes). However, little is currently known about the relationship between chemokines and human obesity. In the present study, we investigated the circulating levels of selected chemokines (monocyte chemoattractant protein-1 (MCP-1), macrophage inflammatory protein-1a (MIP-1a), leukotactin-1, interleukin-8 (IL-8)) and the association between the chemokine levels and obesity-related parameters: body mass index (BMI), waist circumference, fasting glucose and insulin levels, lipids profile, and the level of C-reactive protein (CRP). Methods: A total of 100 subjects, 50 obese (BMIX25 kg/m 2 ) and 50 who were not obese (BMIo25 kg/m 2 ) participated in the present study. The levels of chemokines and CRP were measured in a fasting state serum by sandwich enzyme-linked immunosorbent assay. Total cholesterol, high-density lipoprotein (HDL)-cholesterol, triglyceride, glucose, and insulin levels were measured by enzymatic analysis and immunoassay. Results: The circulating levels of MCP-1 and IL-8 in the serum were significantly (Po0.05) higher in obese subjects (BMI430 kg/ m 2 ) compared with those of nonobese controls (BMIo25 kg/m 2 ). The levels of CRP were positively correlated with BMI (Po0.001) or waist circumference (Po0.0001). The levels of MCP-1 and IL-8 were positively related to BMI (MCP-1, Po0.02; IL-8, Po0.01) and/or waist circumference (MCP-1, Po0.009; IL-8, Po0.03). The levels of MCP-1 were positively related to the levels of CRP (Po0.007) or interleukin-6 (IL-6) (Po0.0001), and negatively related to the levels of HDL-cholesterol (Po0.01). Homeostasis model assessment (HOMA) score was positively related to the levels of MCP-1 (Po0.02) or IL-8 (Po0.03) in obese subject. Discussion: Our data demonstrated that the circulating levels of MCP-1 and IL-8 are related to obesity-related parameters such as BMI, waist circumference, CRP, IL-6, HOMA and HDL-cholesterol. These findings suggest that the circulating MCP-1 and/or IL-8 may be a potential candidate linking obesity with obesity-related metabolic complications such as atherosclerosis and diabetes.
Introduction
Obesity is known to increase the risk for many pathological processes including type 2 diabetes and cardiovascular diseases. Several lines of evidence suggest that obesity is a low-grade systemic inflammatory condition accompanied by increased levels of circulating C-reactive protein (CRP) and/ or other inflammatory cytokines such as tumor necrosis factor alpha (TNFa) and interleukin-6 (IL-6). [1] [2] [3] [4] Adipocytokines such as TNFa or IL-6 are generally elevated with increasing adiposity, 5, 6 and are closely correlated with CRP, 7 a known inflammatory marker. 8 These inflammatory adipocytokines are considered to play an important role in the development of metabolic complications in obesity.
Recent studies have shown that adipocytes express chemotactic cytokines called chemokines (e.g. monocyte chemoattractant protein-1 (MCP-1); macrophage inflammatory protein-1a (MIP-1a); macrophage inflammatory proteinrelated protein-2 (MRP-2) and interleukin-8 (IL-8)) and their receptors. 9, 10 Interestingly, the gene expression and the protein secretion of MCP-1, MIP-1a and/or MRP-2 are markedly enhanced in adipocyte and adipose tissue of obese animals, [10] [11] [12] presumably contributing to the inflammatory milieu in obesity. Monocyte chemoattractant protein-1 decreases insulin-stimulated glucose uptake in adipocytes, indicating the involvement of MCP-1 in insulin resistance. 11 Chemokines such as MCP-1, IL-8 and leukotactin-1 also play a pivotal role in the development of atherosclerosis by enhancing adhesion molecules on leukocytes and endothelial cells, as well as inducing leukocyte infiltration into the vascular subendothelial area. 13, 14 Recent studies have
shown that visceral adipose tissue releases more than the subcutaneous and circulating IL-8 is elevated in obesity. 15, 16 These findings suggest the possibility that the elevation of chemokines with expanding adiposity contributes to obesity-related pathologies such as diabetes and atherosclerosis. However, little is currently known whether chemokines are associated with human obesity or obesity-related parameters.
In the present study, we investigated the association between the circulating levels of selected chemokines (MCP-1, MIP-1a, Lkn-1 and IL-8) and obesity-related parameters, which are known to be elevated in obesity, such as a waist circumference, body mass index (BMI), lipid profiles, homeostasis model assessment (HOMA) score and CRP levels. The present study demonstrates that the circulating MCP-1 and/or IL-8 are closely related to obesity-related parameters.
Subjects and methods
Patients (Korean) diagnosed with obesity were included in the study. Obesity was defined as a BMIX25 kg/m 2 based on the Asia-Pacific criteria set by the World Health Organization. 17 A total of 100 subjects participated in the study; 50 obese subjects had a BMI425 kg/m 2 and a normal medical history. Among these 50 obese subjects, 23 (20 women and three men) met the Asia-Pacific criteria for mild obesity (BMI 25-29.9 kg/m 2 ), 26 obese subjects (17 women and nine men) for severe obesity (BMIX30 kg/m 2 ), and one obese subject (one woman) for morbid obesity (BMIX40 kg/m 2 ). The control group was age and sex matched and contained 50 healthy subjects (BMIo25 kg/m 2 ). Excluded from this study were individuals with severe inflammatory or infectious diseases, cancers, secondary causes of obesity, pregnant or lactating women, subjects with evidence of severe hepatic or renal disease, and subjects using medication, including antihypertensive drugs, oral hypoglycemic agents, insulin, and hypolipidemic agents. All individuals were subjected to a medical evaluation by a physician, including a full medical history and physical examination. Fasting blood samples were taken into pyrogen-free blood collection tubes and were centrifuged within 30 min (1000 g at 41C). Serum samples were stored at À801C in multiple aliquots until analysis. The study was approved by an institutional review board of Asan medical center and was conducted according to the principles of the Helsinki Declaration.
Total cholesterol and high-density lipoprotein (HDL) cholesterol, and triglyceride were measured by enzymatic assay (Asan Pham., Hwa-Sung, Korea). Low-density lipoprotein (LDL) cholesterol was calculated by the Friedwald fomula LDL-C ¼ TC-(HDL-C þ TG/5). 18 High-density lipoprotein-cholesterol was measured by a direct method (Wako Pure Chemical Industries, Osaka, Japan). Blood glucose levels were measured by the glucose oxidase method. Blood insulin was measured by radioimmunoassay (Dianabott, Japan). The estimate of insulin resistance by HOMA score was calculated with the formula: fasting serum insulin (U/ml) Â fasting plasma glucose (mmol/l)/22.5. 19 Body mass index (kg/m 2 ) was computed from the participant's weight and height. The waist circumference between the rib cage and the iliac crest with the subject in the standing position was measured. Systolic and diastolic blood pressure was measured by a mercury sphygmomanometer on the right arm after at least a 5-min rest. 
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The serum levels of chemokines (MCP-1, MIP-1a, Lkn-1 and IL-8) were measured by enzyme-linked immunosorbent assay (ELISA, R&D system, Minneapolis, USA) according to the manufacturer's instruction. Tumor necrosis factor alpha and IL-6 were determined by a high-sensitivity ELISA (Quantikine, R&D system, Minneapolis, USA). The assay for serum CRP was measured using the CRP kit (ALerCHEK, Inc., Portland, OR, USA).
Statistical analyses
Data were expressed as the means7s.e.m., and statistical analyses including two-sample Student's t-test, correlation analyses, and linear regression analyses were performed using the PC version of the computer program SAS 8.0 (SAS Institute Inc., Cary, NC, USA). Differences were considered to be significant at Po0.05.
Results
General characteristics of study subjects General characteristics and laboratory parameters relative to the obese subjects and the nonobese subjects (controls) are shown in Table 1 . There was no significant difference in age, fasting glucose, male:female ratio between the obese subjects and nonobese controls.
Circulating levels of chemokine in obese and nonobese subjects Circulating levels of MCP-1 (Po0.05) and IL-8 (Po0.04) were significantly higher in obese subjects with BMI430 kg/m 2 compared to those of nonobese subjects (BMIo25 kg/m 2 ), while the chemokines did not significantly increase in mildly obese subjects with BMI 25-29.9 kg/m 2 ( Figure 1 ).
The BMI was correlated to the levels of MCP-1 (g ¼ 0.230, Po0.02), IL-8 (g ¼ 0.250, Po0.01), and no relation was observed between BMI and the levels of MIP-1a or Lkn-1 (data not shown). 
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The circulating levels of MCP-1 (g ¼ 0.278, Po0.009), IL-8 (g ¼ 0.235, Po0.03) and Lkn-1 (g ¼ 0.242, Po0.02) were positively correlated to waist circumference, but the levels of MIP-1a (g ¼ 0.118, Po0.29) was not. The serum levels of MCP-1 were positively related to the levels of MIP-1a (g ¼ 0.777, Po0.0001) (Figure 2a  and b) .
Relationship between BMI or waist circumference and C-reactive protein Circulating levels of CRP were significantly (Po0.04) elevated in obese subjects compared with nonobese controls (Table 1) , and closely associated with BMI (g ¼ 0.650, Po0.001) (Figure 3a 
Relationship between the circulating levels of chemokine and C-reactive protein in obese subjects Relationship between serum chemokine levels and CRP was determined by a regression analysis in obese subjects with BMI430 kg/m 2 . As shown in Figure 4 , the levels of CRP were positively correlated with the levels of MCP-1 (g ¼ 0.516, Po0.007) or MIP-1a (g ¼ 0.620, Po0.002) and IL-8 (g ¼ 0.542, Po0.03), but not correlated with the levels of Lkn-1 (g ¼ 0.139, Po0.49).
Relationship between the circulating levels of chemokine and high-density lipoprotein-cholesterol in obese subjects The levels of HDL-cholesterol was negatively related to the levels of MCP-1 (g ¼ À0.374, Po0.01), MIP-1a Chemokines and obesity-related parameters C-S Kim et al (g ¼ À0.319, Po0.04), but did not to Lkn-1 (g ¼ À0.125, Po0.39) or IL-8 (g ¼ À0.261, Po0.11) in obese subjects ( Figure 5 ). The levels of chemokines were not related to TG, total cholesterol, LDL-cholesterol, and systolic blood pressure in obese subjects (data not shown).
Relationship between the circulating levels of chemokine and insulin in obese subjects As shown in Figure 6 , HOMA score was positively related to the levels of MCP-1 (g ¼ 0.344, Po0.02) and IL-8 (g ¼ 0.334, Po0.03), but did not to Lkn-1 (g ¼ 0.154, Po0.31) or MIP-1a (g ¼ 0.082, Po0.63) in obese subjects. 
The levels of MCP-1 (g ¼ 0.850, Po0.0001) or IL-8 (g ¼ 0.647, Po0.0001) were positively related to the levels of IL-6 ( Figure 7 ), but not to the levels of TNFa.
Discussion
The present study demonstrated that the circulating levels of MCP-1 and IL-8 were significantly higher in obese subjects compared to nonobese controls. The levels of chemokines (MCP-1 and/or IL-8) may be indices linking obesity with obesity-related metabolic complications such as atherosclerosis and/or diabetes.
Recent studies have shown that some chemokines (e.g. MCP-1 and IL-8), are secreted by adipocyte and adipose tissue, and increase with increasing fat mass in animals, 15, 20 as well as obese subjects, 16 implicating these particular chemokines might be involved in the development of obesity-related pathologies. When looking at the association between the circulating levels of chemokines and BMI in all subjects, we observed that the levels of MCP-1 and IL-8 were significantly increased in obese subjects with BMI430 kg/m 2 compared with the nonobese controls. It has been shown that MCP-1 and IL-8 are secreted by human mature adipocyte and from cultured adipose tissue. 9, 21 The expression and circulating levels of MCP-1 increased in genetically obese mice, 11 as well as in high fat diet-induced obese mice. 22 Our findings suggest that human adiposity with a BMI of more than 30 kg/m 2 can influence the circulating levels of chemokines such as MCP-1 and IL-8. Interestingly, recent studies have shown that visceral adipose tissue is a major source of chemokine such as IL-8 in obesity. 15 Our data demonstrated that the circulating levels of MCP-1 and IL-8 significantly increased with increasing waist circumference, supporting the idea that visceral fat may play a role in the elevation of circulating MCP-1 and IL-8 in obesity. MCP-1 and MIP-1a are highly related members of the CC chemokine subfamily, but the levels of MCP-1 were much higher than those of MIP-1a in obesity. It appears that MCP-1 is more relevant to fat mass and/or visceral fat in obesity.
The elevation of certain chemokines is often observed in inflammatory tissues (e.g. infection, autoimmune diseases, atherosclerotic lesions etc.) and the circulatory system. 23, 24 Therefore, we hypothesized that chemokines are associated with inflammatory condition in obesity. C-reactive protein, a classical acute-phase protein, is a marker of the inflammatory cascade and the levels of CRP are known to increase in obesity as well as cardiovascular disease. In agreement with other reports, 25, 26 we observed that the levels of CRP, were significantly elevated in obese subjects compared to nonobese subjects, and closely associated with BMI. These findings were consistent with other reports. 7, 27 The levels of CRP were positively correlated with the levels of MCP-1 and MIP-1a, providing a link between these chemokines and the low-grade inflammatory condition found in obesity. A recent study has shown that CRP enhances chemokine expression such as MCP-1 and IL-8 in the human endothelial cell. 28 Therefore, the elevation of MCP-1 or IL-8 levels in obesity may implicate the influence of CRP. However, it is not clear whether CRP causes the elevation of the chemokines or vice versa in human obesity. Our data suggests that the circulating levels of MCP-1, MIP-1a and IL-8 may, at least, reflect the inflammatory condition in obesity. In general, obesity, the most common cause of insulin resistance, is associated with dyslipidemia and type 2 diabetes as well as vascular complications, which is collectively called metabolic syndrome. It has been shown that serum IL-6 or IL-8 levels increase in type 2 diabetic patients or obese subjects. 29, 30 MCP-1 was also reported to decrease insulin-stimulated glucose uptake in adipocytes, indicating the involvement of the chemokines in insulin resistance.
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Our data demonstrated that the levels of MCP-1 or IL-8 were positively related to the levels of IL-6 and HOMA score in obese subjects, supporting the idea that these chemokines contribute to insulin resistance in obesity. Circulating levels of MCP-1 and IL-8 have also been shown to be high in atherosclerosis patients 31 and both chemokines are Chemokines and obesity-related parameters C-S Kim et al implicated in the development of atherosclerosis by stimulating vascular endothelial cells and trafficking macrophages into arterial intima. 13 We also observed that the levels of MCP-1 were negatively correlated to the levels of HDLcholesterol and positively to CRP in obese, and IL-8 showed the similar tendency. Considering the fact that HDLcholesterol or CRP is a strong predictor of cardiovascular disease, 32, 33 the chemokines may be implicated in the development of vascular complications in obesity. Regarding TNFa, it appears that circulating soluble TNFa receptor levels may be more relevant to insulin resistance, as previously reported. 34 In conclusion, the circulating levels of chemokines such as MCP-1 and IL-8 were significantly higher in human obese subjects compared with nonobese subjects. The levels of chemokines (MCP-1 and IL-8) are related to the obesityrelated parameters such as BMI, waist circumference, the levels of CRP, HDL-cholesterol, and HOMA score. Taken together, we suggest that the circulating levels of MCP-1 and IL-8 may be a potential candidate linking obesity with obesity-related metabolic complications such as diabetes and atherosclerosis.
